Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
Claude 4.5 is available everywhere today. Through the API, the model maintains the same pricing as Claude Sonnet 4, at $3 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback